MUSC Hollings Cancer Center

Hollings in the Headlines

AACR Highlights Surgeon General’s Report in which HCC Researchers Made Significant Contributions

As part of the 2014 American Association for Cancer Research (AACR) Annual Meeting in San Diego, a press conference and scientific session were held April 7, 2014, highlighting the profound findings from the 2014 Surgeon General’s Report (SGR).  The special session, “Honoring the Surgeon General’s Anniversary Report: 50 Years of Progress”, discussed the tremendous progress made in curbing the adverse effects of tobacco through national and international tobacco control efforts.  The session also highlighted the need for continued work to curb the coming health crises that continue due to ongoing tobacco use.  Dr. Graham Warren, Vice Chairman for Research in Radiation Oncology and Director of the Tobacco Assessment and Cessation Program at the Hollings Cancer Center, presented findings from the SGR, which concluded that smoking by cancer patients and survivors increased overall and cancer specific mortality, risk of second primary cancer, and was associated with increased cancer treatment toxicity.  “These conclusions now represent the evidence-base to effect significant changes in the way cancer patients are treated,” says Dr. Warren.  “The broad negative health effects of tobacco continue even after a cancer diagnosis.  It is critically important to understand how tobacco decreases the effectiveness of cancer treatment and clinicians must now use this evidence to provide tobacco cessation support for all cancer patients in order to provide evidence-based cancer care.”

Dr. Warren also provided testimony to the U.S. Food and Drug Administration (FDA) Center for Tobacco Products while at the AACR meeting.

Pictured in front of an exhibit at AACR on the SGR and the timeline of tobacco control efforts created by Dr. K. Michael Cummings are (from left to right) Dr. Roy S. Herbst, M.D., Ph.D., chief of medical oncology at Yale Cancer Center; Mitch Zeller, J.D., director of the FDA’s Center for Tobacco Products; Dr. Ellen R. Gritz, Ph.D., professor and chair of the Department of Behavioral Science at the University of Texas MD Anderson Cancer Center; Dr. Robert Croyle, Ph.D., director of the Division of Cancer Control and Population Sciences at the National Cancer Institute; and Dr. Graham Warren, M.D., Ph.D. 

The Hollings Cancer Center at the Medical University of South Carolina played a significant role in the evidence presented in the 2014 SGR.  Dr. Anthony Alberg, Professor and Blatt Ness Endowed Chair of Oncology, Dr. Cummings, Professor in the Department of Psychiatry and Behavioral Science, and Dr. Warren were contributors on the 2014 SGR.  Recognizing the need to address the evidence-based negative effects of tobacco on cancer treatment, Hollings Cancer Center is now supporting the development of tobacco cessation services available for all cancer patients.  Information on tobacco cessation services can be obtained by contacting Dr. Warren or Dr. Katherine Hoover, Pharm.D., at 843-792-2878.


* This website is best viewed in Firefox or Chrome internet browsers.